Conversion Labs: Telehealth Subscriptions

By -

 

  • Conversion Labs was highlighted in a bull call by Citron Research.
  • The company is building a DTC health and wellness platform focused on subscription services.
  • Q4 revenues surged 265% to $13.6 million.
  • The stock is cheap compared to other telehealth brands trading at less than 5x EV/S multiples.
  • This idea was discussed in more depth with members of my private investing community, Out Fox The Street. Get started today »

The telehealth space was hot in 2020 and Conversion Labs (CVLB) is playing perfectly into this trend. The company is quickly ramping up some new direct-to-consumer subscription services while building a telehealth platform for future products. The stock is appealing here after a notable firm made a bullish case on the stock.

Read the full article on Seeking Alpha. 

Update - March 18

A couple of weeks ago, LifeMD predicted Q1 revenue to reach $17 million. After the close, $HIMS reported a solid revenue beat for Q4. $LFMD reports after the close on the 29th. 

-Him & Hers Health (NYSE:HIMS): Q4 GAAP EPS of -$0.07 beats by $0.13.
-Revenue of $41.47M (+67.4% Y/Y) beats by $4.47M.


Disclosure: No positioned mentioned. Please review the disclaimer page for more details. 

Comments

Post a Comment

Popular posts from this blog

Stat of the Day: Leading Indicators Jump Again

By -
The Conference Board reported this morning that Leading Economic Indicators for October came in at 0.9% easily surpassing expectation (how is that considering the numbers are known?).  The leading indicators are usually an accurate predictor of economic conditions in the next months. This number continues to increase at a solid clip. If only the US market could focus on leading indicators like these and jobless claims and less on Europe. Not going to spend much time highlighting the individual components because it just doesn't matter. The numbers have been strong and will likely continue as like as monetary policy is accomondative. It likely won't change until investors become overly bullish on the stock market. The economy will continue rolling along producing jobless claims below expectations, but the stock market will get roiled by Europe. Some day though that will end and this bullish data will matter. 10:02 AM   Oct. Leading Indicators:  Leading Index  +0.9%  vs
Read more

Aurora Cannabis: Deal Or No Deal

By -
Aurora Cannabis was left out of the major deal making in 2018. The cannabis company updated FQ2 guidance to revenues of $50 to $55 million with a continued focus on pure production growth. The stock is down as the market is becoming less impressed with commodity farming operations due to the prime Oregon example. The stock is below key resistance at $5.40 as medical cannabis patient totals failed to impress. As the end of 2018 came and went,   Aurora Cannabis   ( ACB ) was a notable absentee from the deal making in the cannabis market. Just about all of the other major Canadian cannabis players got large investments or signed up powerful partnerships, but the related stocks didn't generally maintain rallies following the deals. Based on the early legalization data in Canada and Oregon, the best option for Aurora Cannabis might actually be selling production capacity while the Canadian market remains hot. Read the full article on Seeking Alpha.  Disclosure: No
Read more

Kohl's: Worth $75 Without Financial Engineering

By -
Image
  Kohl's has activists wanting the company to spin off the e-commerce division to unlock value. The company already has plans to grow the business and activists have yet to show how a full omni-channel business can operate as two different companies. The stock is absurdly cheap at 7x EPS targets and Kohl's will repurchase over 15% of the outstanding shares this year. Looking for more investing ideas like this one? Get them exclusively at Out Fox The Street.   Learn More » After an outstanding quarter with business booming,  Kohl's  ( KSS ) faces activists wanting to break up the business. The omni-channel retailer is facing the same pressure as other department stores to separate the e-commerce business in what amounts to financial engineering. My  investment thesis  remains very bullish on the retailer as the company reinvents the shopping experience. Read the full article on Seeking Alpha.  Disclosure: Long KSS. Please read the disclaimer page for more details.  Update -
Read more